.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Healthtrust
Accenture
Novartis
Chinese Patent Office
Covington
McKesson
Fish and Richardson
Cantor Fitzgerald

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203469

« Back to Dashboard
NDA 203469 describes ICLUSIG, which is a drug marketed by Ariad and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the ICLUSIG profile page.

The generic ingredient in ICLUSIG is ponatinib hydrochloride. One supplier is listed for this compound. Additional details are available on the ponatinib hydrochloride profile page.

Summary for NDA: 203469

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 203469

Mechanism of ActionProtein Kinase Inhibitors

Suppliers and Packaging for NDA: 203469

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ICLUSIG
ponatinib hydrochloride
TABLET;ORAL 203469 NDA ARIAD Pharmaceuticals, Inc. 76189-533 76189-533-30 30 TABLET, FILM COATED in 1 BOTTLE (76189-533-30)
ICLUSIG
ponatinib hydrochloride
TABLET;ORAL 203469 NDA ARIAD Pharmaceuticals, Inc. 76189-534 76189-534-30 30 TABLET, FILM COATED in 1 BOTTLE (76189-534-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 15MG BASE
Approval Date:Dec 14, 2012TE:RLD:Yes
Patent:8,114,874Patent Expiration:Dec 22, 2026Product Flag?YSubstance Flag?YDelist Request?
Patent:9,493,470Patent Expiration:Dec 12, 2033Product Flag?YSubstance Flag?YDelist Request?
Patent:9,029,533Patent Expiration:Dec 22, 2026Product Flag?Substance Flag?Delist Request?
Patented Use:A METHOD FOR THE TREATMENT OF LEUKEMIAS


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
McKinsey
AstraZeneca
QuintilesIMS
Farmers Insurance
Dow
Queensland Health
Colorcon
Boehringer Ingelheim
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot